{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:43:11Z","timestamp":1790476991017,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Attention deficit hyperactivity disorder (ADHD) is a relatively common disorder in clinical psychiatry. Patients often suffer from symptoms long before the diagnosis due to an overlap with other psychiatric differential diagnosis. Importantly, alcohol addiction and other illicit drug dependence and withdrawal symptoms mimicking ADHD symptoms should be ruled out. Here we present a rare case of a young female patient with symptoms of ADHD and an extremely high carbohydrate-deficient transferrin (CDT) of 19,6% (&lt;\u20091,3%) indicating the presence of a congenital disorder of glycosylation (CDG). A thorough diagnostic workup excluded alcohol addiction as a cause of the constantly high CDT levels. The CDT test was positive due a transferrin mutation affecting the glycosylation site. Nevertheless, psychiatric symptoms can be due to metabolic disorders which should be considered. Further, substance-use disorders (SUD) are a critical and potentially complicated differential diagnosis concerning diagnostic procedures and treatment in ADHD.<\/jats:p>","DOI":"10.1186\/s12888-025-06862-9","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:50:47Z","timestamp":1745916647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The long way to diagnosis: attention disorder, alcohol addiction or congenital disorder of glycosylation? A case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Timo Jendrik","family":"Faustmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Bahic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Gr\u00fcneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonhard","family":"Schilbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"3","key":"6862_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1192\/bjp.bp.107.048827","volume":"194","author":"V Simon","year":"2009","unstructured":"Simon V, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204\u201311. https:\/\/doi.org\/10.1192\/bjp.bp.107.048827","journal-title":"Br J Psychiatry"},{"issue":"4","key":"6862_CR2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","volume":"163","author":"RC Kessler","year":"2006","unstructured":"Kessler RC, et al. The prevalence and correlates of adult ADHD in the united States: results from the National comorbidity. Surv Replication Am J Psychiatry. 2006;163(4):716\u201323. https:\/\/doi.org\/10.1176\/ajp.2006.163.4.716","journal-title":"Surv Replication Am J Psychiatry"},{"key":"6862_CR3","doi-asserted-by":"publisher","unstructured":"Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol med. 2006;36(2):159\u201365. https:\/\/doi.org\/10.1017\/S003329170500471X","DOI":"10.1017\/S003329170500471X"},{"issue":"2","key":"6862_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.psc.2003.12.003","volume":"27","author":"L Adler","year":"2004","unstructured":"Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit\/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187\u2013201. https:\/\/doi.org\/10.1016\/j.psc.2003.12.003","journal-title":"Psychiatr Clin North Am"},{"issue":"17","key":"6862_CR5","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.12998\/wjcc.v7.i17.2420","volume":"7","author":"S Gnanavel","year":"2019","unstructured":"Gnanavel S, et al. Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019;7(17):2420\u20136. https:\/\/doi.org\/10.12998\/wjcc.v7.i17.2420","journal-title":"World J Clin Cases"},{"key":"6862_CR6","doi-asserted-by":"publisher","unstructured":"Salvi V, et al. ADHD and bipolar disorder in adulthood: clinical and treatment implications. Med (Kaunas). 2021;57(5). https:\/\/doi.org\/10.3390\/medicina57050466","DOI":"10.3390\/medicina57050466"},{"key":"6862_CR7","unstructured":"DGKJP, DGPPN, DGSPJ, S3-Leitlinie ADHS bei Kindern, Jugendlichen und Erwachsenen; 2017. Available from: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/028-045"},{"issue":"11","key":"6862_CR8","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1176\/ps.48.11.1378","volume":"48","author":"R Milin","year":"1997","unstructured":"Milin R, et al. Assessment of symptoms of attention-deficit hyperactivity disorder in adults with substance use disorders. Psychiatr Serv. 1997;48(11):1378\u2013801395. https:\/\/doi.org\/10.1176\/ps.48.11.1378","journal-title":"Psychiatr Serv"},{"issue":"Suppl 1","key":"6862_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/10550490601082783","volume":"16","author":"JJ Mariani","year":"2007","unstructured":"Mariani JJ, Levin FR. Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict. 2007;16(Suppl 1):45\u201354. quiz 55-6. https:\/\/doi.org\/10.1080\/10550490601082783","journal-title":"Am J Addict"},{"issue":"12","key":"6862_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/clinchem\/37.12.2029","volume":"37","author":"H Stibler","year":"1991","unstructured":"Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem. 1991;37(12):2029\u201337.","journal-title":"Clin Chem"},{"issue":"1","key":"6862_CR11","first-page":"34","volume":"25","author":"P Sillanaukee","year":"2001","unstructured":"Sillanaukee P, et al. Possible reasons why heavy drinking increases carbohydrate- deficient transferrin. Alcohol Clin Exp Res. 2001;25(1):34\u201340.","journal-title":"Alcohol Clin Exp Res"},{"key":"6862_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jpba.2017.09.006","volume":"147","author":"F Bortolotti","year":"2018","unstructured":"Bortolotti F, et al. Analytical and diagnostic aspects of carbohydrate deficient transferrin (CDT): A critical review over years 2007\u20132017. J Pharm Biomed Anal. 2018;147:2\u201312. https:\/\/doi.org\/10.1016\/j.jpba.2017.09.006","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"6862_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/10937400490432400","volume":"7","author":"K Golka","year":"2004","unstructured":"Golka K, Wiese A. Carbohydrate-deficient transferrin (CDT)--a biomarker for long-term alcohol consumption. J Toxicol Environ Health B Crit Rev. 2004;7(4):319\u201337. https:\/\/doi.org\/10.1080\/10937400490432400","journal-title":"J Toxicol Environ Health B Crit Rev"},{"issue":"2","key":"6862_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/alcalc\/agq092","volume":"46","author":"V Bianchi","year":"2011","unstructured":"Bianchi V, et al. Pregnancy and variations of carbohydrate-deficient transferrin levels measured by the candidate reference HPLC method. Alcohol Alcohol. 2011;46(2):123\u20137. https:\/\/doi.org\/10.1093\/alcalc\/agq092","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"6862_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1203\/PDR.0b013e318068641a","volume":"62","author":"E Pronicka","year":"2007","unstructured":"Pronicka E, et al. Elevated carbohydrate-deficient transferrin (CDT) and its normalization on dietary treatment as a useful biochemical test for hereditary Fructose intolerance and galactosemia. Pediatr Res. 2007;62(1):101\u20135. https:\/\/doi.org\/10.1203\/PDR.0b013e318068641a","journal-title":"Pediatr Res"},{"issue":"5","key":"6862_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/003655101316911378","volume":"61","author":"U Nihlen","year":"2001","unstructured":"Nihlen U, et al. Increased serum levels of carbohydrate-deficient transferrin in patients with chronic obstructive pulmonary disease. Scand J Clin Lab Invest. 2001;61(5):341\u20137. https:\/\/doi.org\/10.1080\/003655101316911378","journal-title":"Scand J Clin Lab Invest"},{"issue":"10","key":"6862_CR17","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1515\/CCLM.2000.143","volume":"38","author":"C Colome","year":"2000","unstructured":"Colome C, et al. Personal experience with the application of carbohydrate-deficient transferrin (CDT) assays to the detection of congenital disorders of glycosylation. Clin Chem Lab Med. 2000;38(10):965\u20139. https:\/\/doi.org\/10.1515\/CCLM.2000.143","journal-title":"Clin Chem Lab Med"},{"key":"6862_CR18","doi-asserted-by":"publisher","unstructured":"Freeze HH, Jaeken J, Matthijs G. CDG or not CDG J Inherit Metab Dis. 2022;45(3):383\u20135. https:\/\/doi.org\/10.1002\/jimd.12498","DOI":"10.1002\/jimd.12498"},{"key":"6862_CR19","unstructured":"Freeze HH, Schachter H, Kinoshita T. Genetic disorders of glycosylation. In: Varki A, et al. editors. Essentials of glycobiology. Cold Spring Harbor (NY; 2015;569\u201382)."},{"key":"6862_CR20","doi-asserted-by":"publisher","unstructured":"Chang IJ, He M, Lam CT. Congenital Disorders Glycosylation Ann Transl Med. 2018;6(24):477. https:\/\/doi.org\/10.21037\/atm.2018.10.45","DOI":"10.21037\/atm.2018.10.45"},{"key":"6862_CR21","doi-asserted-by":"publisher","first-page":"p715151","DOI":"10.3389\/fped.2021.715151","volume":"9","author":"P Lipinski","year":"2021","unstructured":"Lipinski P, Tylki-Szymanska A. Congenital disorders of glycosylation: what clinicians need to know?? Front Pediatr. 2021;9:p715151. https:\/\/doi.org\/10.3389\/fped.2021.715151","journal-title":"Front Pediatr"},{"issue":"11","key":"6862_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ejmg.2017.10.012","volume":"61","author":"R Peanne","year":"2018","unstructured":"Peanne R, et al. Congenital disorders of glycosylation (CDG): quo vadis? Eur J Med Genet. 2018;61(11):643\u201363. https:\/\/doi.org\/10.1016\/j.ejmg.2017.10.012","journal-title":"Eur J Med Genet"},{"key":"6862_CR23","doi-asserted-by":"publisher","unstructured":"Dave MB, et al. Comparison of transferrin isoform analysis by capillary electrophoresis and HPLC for screening congenital disorders of glycosylation. J Clin Lab Anal. 2018;32(1). https:\/\/doi.org\/10.1002\/jcla.22167","DOI":"10.1002\/jcla.22167"},{"key":"6862_CR24","doi-asserted-by":"publisher","first-page":"735348","DOI":"10.3389\/fgene.2021.735348","volume":"12","author":"JH Park","year":"2021","unstructured":"Park JH, Marquardt T. Treatment options in congenital disorders of glycosylation. Front Genet. 2021;12:735348. https:\/\/doi.org\/10.3389\/fgene.2021.735348","journal-title":"Front Genet"},{"issue":"6","key":"6862_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00431-002-1136-0","volume":"162","author":"T Marquardt","year":"2003","unstructured":"Marquardt T, Denecke J. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies. Eur J Pediatr. 2003;162(6):359\u201379. https:\/\/doi.org\/10.1007\/s00431-002-1136-0","journal-title":"Eur J Pediatr"},{"key":"6862_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","volume":"89","author":"DS Riley","year":"2017","unstructured":"Riley DS, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017;89:218\u201335. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.04.026","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"6862_CR27","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, et al. Assessment of alcohol withdrawal: the revised clinical Institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353\u20137. https:\/\/doi.org\/10.1111\/j.1360-0443.1989.tb00737.x","journal-title":"Br J Addict"},{"issue":"2","key":"6862_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/s0033291704002892","volume":"35","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, et al. The world health organization adult ADHD Self-Report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245\u201356. https:\/\/doi.org\/10.1017\/s0033291704002892","journal-title":"Psychol Med"},{"issue":"5","key":"6862_CR29","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1055\/s-0035-1552699","volume":"43","author":"P Retz-Junginger","year":"2016","unstructured":"Retz-Junginger P, et al. [ADHD: burden of disease according to subtypes in adult patients]. Psychiatr Prax. 2016;43(5):279\u201382. https:\/\/doi.org\/10.1055\/s-0035-1552699","journal-title":"Psychiatr Prax"},{"key":"6862_CR30","unstructured":"R\u00f6sler M, Retz-Junginger P, Retz W, Stieglitz R-D. Homburger ADHS-Skalen f\u00fcr Erwachsene, 2., \u00fcberarbeitete und erg\u00e4nzte Auflage. CJ Hogrefe, 2021."},{"issue":"7","key":"6862_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1055\/s-0033-1335740","volume":"81","author":"W Retz","year":"2013","unstructured":"Retz W, et al. [Standardised psychopathological rating scales for the diagnosis of ADHD in adults]. Fortschr Neurol Psychiatr. 2013;81(7):381\u20139. https:\/\/doi.org\/10.1055\/s-0033-1335740.","journal-title":"Fortschr Neurol Psychiatr"},{"key":"6862_CR32","doi-asserted-by":"publisher","unstructured":"Retz-Junginger P et al. [Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit\/hyperactivity disorder]. Nervenarzt, 2003;74(11):987\u2013\u200993. https:\/\/doi.org\/10.1007\/s00115-002-1447-4","DOI":"10.1007\/s00115-002-1447-4"},{"issue":"6","key":"6862_CR33","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1176\/ajp.150.6.885","volume":"150","author":"MF Ward","year":"1993","unstructured":"Ward MF, Wender PH, Reimherr FW. The Wender Utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885\u201390. https:\/\/doi.org\/10.1176\/ajp.150.6.885","journal-title":"Am J Psychiatry"},{"issue":"5","key":"6862_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1600-0404.1995.tb07018.x","volume":"91","author":"S Lehrl","year":"1995","unstructured":"Lehrl S, Triebig G, Fischer B. Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand. 1995;91(5):335\u201345. https:\/\/doi.org\/10.1111\/j.1600-0404.1995.tb07018.x","journal-title":"Acta Neurol Scand"},{"key":"6862_CR35","doi-asserted-by":"crossref","unstructured":"Beck AT, Steer RA, Brown GK. Manual for the Beck depression Inventory - Second edition. 1996 (San Antonio, TX: Psychological Corporation).","DOI":"10.1037\/t00742-000"},{"key":"6862_CR36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371. https:\/\/doi.org\/10.1001\/archpsyc.1961.01710120031004","journal-title":"Arch Gen Psychiatry"},{"key":"6862_CR37","unstructured":"Brickenkamp R, Zillmer E. Test d2: Concentration-Endurance test. CJ Hogrefe; 1998."},{"key":"6862_CR38","unstructured":"Kuhl J, Kaz\u00e9n M. Pers\u00f6nlichkeits-Stil- und St\u00f6rungs-Inventar (PSSI). Manual [Personality Style and Disorder inventory (PSDI). CJ Hogrefe, 2009."},{"issue":"1","key":"6862_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/a:1005653411471","volume":"31","author":"S Baron-Cohen","year":"2001","unstructured":"Baron-Cohen S, et al. The autism-spectrum quotient (AQ): evidence from asperger syndrome\/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31(1):5\u201317. https:\/\/doi.org\/10.1023\/a:1005653411471","journal-title":"J Autism Dev Disord"},{"key":"6862_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1744-859X-9-20","volume":"9","author":"IH Aas","year":"2010","unstructured":"Aas IH. Global assessment of functioning (GAF): properties and frontier of current knowledge. Ann Gen Psychiatry. 2010;9:20. https:\/\/doi.org\/10.1186\/1744-859X-9-20","journal-title":"Ann Gen Psychiatry"},{"key":"6862_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-244X-10-67","volume":"10","author":"SJ Kooij","year":"2010","unstructured":"Kooij SJ, et al. European consensus statement on diagnosis and treatment of adult ADHD. BMC Psychiatry. 2010;10:67. https:\/\/doi.org\/10.1186\/1471-244X-10-67. The European Network Adult ADHD.","journal-title":"BMC Psychiatry"},{"key":"6862_CR42","unstructured":"ICD-10-GM Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, German Modification. 2024; Available from: https:\/\/www.bfarm.de\/DE\/Kodiersysteme\/Klassifikationen\/ICD\/ICD-10-GM\/_node.html"},{"key":"6862_CR43","doi-asserted-by":"publisher","unstructured":"Harstad E, Levy S, Committee A on, Substance. Attention-deficit\/hyperactivity disorder and substance abuse. Pediatrics, 2014;134(1):e293-301. https:\/\/doi.org\/10.1542\/peds.2014-0992","DOI":"10.1542\/peds.2014-0992"},{"issue":"5","key":"6862_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3810\/pgm.2014.09.2801","volume":"126","author":"DB Clemow","year":"2014","unstructured":"Clemow DB, Walker DJ. The potential for misuse and abuse of medications in ADHD: a review. Postgrad Med. 2014;126(5):64\u201381. https:\/\/doi.org\/10.3810\/pgm.2014.09.2801","journal-title":"Postgrad Med"},{"key":"6862_CR45","doi-asserted-by":"publisher","unstructured":"Forns J et al. Risk of major cardiovascular and cerebrovascular events in users of Lisdexamfetamine and other medications for Attention-Deficit\/Hyperactivity disorder in Denmark and Sweden: A Population-Based cohort study. Neurol ther, 2022;11(4):1659\u201376. https:\/\/doi.org\/10.1007\/s40120-022-00396-y","DOI":"10.1007\/s40120-022-00396-y"},{"issue":"10","key":"6862_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2165\/11536380-000000000-00000","volume":"33","author":"G Stiefel","year":"2010","unstructured":"Stiefel G. F.M. Besag. Cardiovascular effects of Methylphenidate, amphetamines and Atomoxetine in the treatment of attention-deficit hyperactivity disorder. Drug Saf 2010;33(10):821-42 https:\/\/doi.org\/10.2165\/11536380-000000000-00000","journal-title":"Drug Saf"},{"key":"6862_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1749-6632.2001.tb05783.x","volume":"931","author":"MA Sullivan","year":"2001","unstructured":"Sullivan MA, Rudnik-Levin F. Attention deficit\/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Ann N Y Acad Sci. 2001;931:251\u201370. https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb05783.x","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"6862_CR48","doi-asserted-by":"publisher","first-page":"e24068","DOI":"10.7759\/cureus.24068","volume":"14","author":"BS Srichawla","year":"2022","unstructured":"Srichawla BS, et al. Attention deficit hyperactivity disorder and substance use disorder: A narrative review. Cureus. 2022;14(4):e24068. https:\/\/doi.org\/10.7759\/cureus.24068","journal-title":"Cureus"},{"key":"6862_CR49","doi-asserted-by":"publisher","unstructured":"Wilens TE et al. Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 2003;111(1):179\u2013\u200985. https:\/\/doi.org\/10.1542\/peds.111.1.179","DOI":"10.1542\/peds.111.1.179"},{"issue":"11","key":"6862_CR50","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","volume":"160","author":"ND Volkow","year":"2003","unstructured":"Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003;160(11):1909-18. https:\/\/doi.org\/10.1176\/appi.ajp.160.11.1909","journal-title":"Am J Psychiatry"},{"issue":"8","key":"6862_CR51","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/17512433.2022.2112950","volume":"15","author":"L Carton","year":"2022","unstructured":"Carton L, et al. What is the potential for abuse of Lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion. Expert Rev Clin Pharmacol. 2022;15(8):921\u20135. https:\/\/doi.org\/10.1080\/17512433.2022.2112950","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"6862_CR52","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/jimd.12527","volume":"45","author":"D Albokhari","year":"2022","unstructured":"Albokhari D, et al. ALG8-CDG: molecular and phenotypic expansion suggests clinical management guidelines. J Inherit Metab Dis. 2022;45(5):969\u201380. https:\/\/doi.org\/10.1002\/jimd.12527","journal-title":"J Inherit Metab Dis"},{"key":"6862_CR53","doi-asserted-by":"publisher","unstructured":"Kianickova K, et al. Alterations in the glycan composition of serum glycoproteins in Attention-Deficit hyperactivity disorder. Int J Mol Sci. 2023;24(10). https:\/\/doi.org\/10.3390\/ijms24108745","DOI":"10.3390\/ijms24108745"},{"issue":"1","key":"6862_CR54","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ajhg.2017.12.009","volume":"102","author":"BG Ng","year":"2018","unstructured":"Ng BG, et al. Biallelic mutations in FUT8 cause a congenital disorder of glycosylation with defective fucosylation. Am J Hum Genet. 2018;102(1):188\u201395. https:\/\/doi.org\/10.1016\/j.ajhg.2017.12.009","journal-title":"Am J Hum Genet"},{"issue":"1","key":"6862_CR55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jmd2.12338","volume":"64","author":"ZJ Xia","year":"2023","unstructured":"Xia ZJ, et al. The Swedish COG6-CDG experience and a comprehensive literature review. JIMD Rep. 2023;64(1):79\u201389. https:\/\/doi.org\/10.1002\/jmd2.12338","journal-title":"JIMD Rep"},{"issue":"1","key":"6862_CR56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41398-023-02446-x","volume":"13","author":"P Pradeep","year":"2023","unstructured":"Pradeep P, Kang H, Lee B. Glycosylation and behavioral symptoms in neurological disorders. Transl Psychiatry. 2023;13(1):154. https:\/\/doi.org\/10.1038\/s41398-023-02446-x","journal-title":"Transl Psychiatry"},{"key":"6862_CR57","doi-asserted-by":"publisher","unstructured":"Paprocka J, et al. Congenital disorders of glycosylation from a neurological perspective. Brain Sci. 2021;11(1). https:\/\/doi.org\/10.3390\/brainsci11010088","DOI":"10.3390\/brainsci11010088"},{"issue":"5","key":"6862_CR58","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1124\/mol.56.5.1071","volume":"56","author":"KD Karpa","year":"1999","unstructured":"Karpa KD, et al. N-linked glycosylation is required for plasma membrane localization of D5, but not D1, dopamine receptors in transfected mammalian cells. Mol Pharmacol. 1999;56(5):1071\u20138. https:\/\/doi.org\/10.1124\/mol.56.5.1071","journal-title":"Mol Pharmacol"},{"key":"6862_CR59","doi-asserted-by":"publisher","unstructured":"Wu J, et al. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol neurobiol. 2012;45(3):605-20. https:\/\/doi.org\/10.1007\/s12035-012-8278-5","DOI":"10.1007\/s12035-012-8278-5"},{"issue":"3","key":"6862_CR60","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.nbd.2009.09.002","volume":"36","author":"D Afonso-Oramas","year":"2009","unstructured":"Afonso-Oramas D, et al. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson\u2019s disease. Neurobiol Dis. 2009;36(3):494\u2013508. https:\/\/doi.org\/10.1016\/j.nbd.2009.09.002","journal-title":"Neurobiol Dis"},{"issue":"6","key":"6862_CR61","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1254\/fpj.20033","volume":"155","author":"C Sakai","year":"2020","unstructured":"Sakai C. Pharmacological properties and clinical effects of the ADHD drug, Lisdexamfetamine (Vyvanse((R)) capsules 20\u00a0mg and 30\u00a0mg). Nihon Yakurigaku Zasshi. 2020;155(6):413\u201325. https:\/\/doi.org\/10.1254\/fpj.20033","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"6862_CR62","doi-asserted-by":"publisher","unstructured":"Frampton JE. Lisdexamfetamine: A Review in ADHD in Adults. CNS Drugs, 2016;30(4):343\u2013\u200954. https:\/\/doi.org\/10.1007\/s40263-016-0327-6","DOI":"10.1007\/s40263-016-0327-6"},{"issue":"6","key":"6862_CR63","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.clinbiochem.2015.12.001","volume":"49","author":"A Grahn","year":"2016","unstructured":"Grahn A, et al. A novel mutation on the transferrin gene abolishes one N- glycosylation site and alters the pattern of transferrin isoforms, mimicking that observed after excessive alcohol consumption. Clin Biochem. 2016;49(6):511\u20133. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.12.001","journal-title":"Clin Biochem"},{"issue":"11","key":"6862_CR64","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jpsychires.2007.10.005","volume":"42","author":"M Qu","year":"2008","unstructured":"Qu M, et al. Polymorphisms of transferrin gene are associated with schizophrenia in Chinese Han population. J Psychiatr Res. 2008;42(11):877\u201383. https:\/\/doi.org\/10.1016\/j.jpsychires.2007.10.005","journal-title":"J Psychiatr Res"},{"key":"6862_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12991-014-0027-x","volume":"13","author":"C Demily","year":"2014","unstructured":"Demily C, Sedel F. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014;13:27. https:\/\/doi.org\/10.1186\/s12991-014-0027-x","journal-title":"Ann Gen Psychiatry"},{"key":"6862_CR66","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.neubiorev.2021.11.012","volume":"132","author":"S Cannon Homaei","year":"2022","unstructured":"Cannon Homaei S, et al. ADHD symptoms in neurometabolic diseases: underlying mechanisms and clinical implications. Neurosci Biobehav Rev. 2022;132:838\u201356. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.11.012","journal-title":"Neurosci Biobehav Rev"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06862-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06862-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06862-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:50:49Z","timestamp":1745916649000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06862-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6862"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06862-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5679698\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for case reports.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"435"}}